[{"orgOrder":0,"company":"The First Affiliated Hospital with Nanjing Medical University","sponsor":"Shandong Qilu Stem Cells Engineering Co., Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"","productType":"Cell and Gene therapy","year":"2023","type":"Inapplicable","leadProduct":"Human Cord Blood Mononuclear Cell","moa":"Undisclosed","graph1":"Podiatry","graph2":"Undisclosed","graph3":"The First Affiliated Hospital with Nanjing Medical University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"The First Affiliated Hospital with Nanjing Medical University \/ Shandong Qilu Stem Cells Engineering Co., Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"The First Affiliated Hospital with Nanjing Medical University \/ Shandong Qilu Stem Cells Engineering Co., Ltd."},{"orgOrder":0,"company":"Changi General Hospital","sponsor":"ELO Water Pte. Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Elo Water","moa":"Undisclosed","graph1":"Podiatry","graph2":"Undisclosed","graph3":"Changi General Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Changi General Hospital \/ ELO Water Pte. Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Changi General Hospital \/ ELO Water Pte. Ltd."},{"orgOrder":0,"company":"Orkla","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"SWEDEN","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Salicylic Acid","moa":"COX-1","graph1":"Podiatry","graph2":"Undisclosed","graph3":"Orkla","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Solution","sponsorNew":"Orkla \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Orkla \/ Inapplicable"},{"orgOrder":0,"company":"TCI Co., Ltd.","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"","productType":"Peptide","year":"2024","type":"Inapplicable","leadProduct":"Marine Collagen Peptides","moa":"Undisclosed","graph1":"Podiatry","graph2":"Undisclosed","graph3":"TCI Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"TCI Co., Ltd. \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"TCI Co., Ltd. \/ Inapplicable"},{"orgOrder":0,"company":"The VA Western New York Healthcare System","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Procenta","moa":"Undisclosed","graph1":"Podiatry","graph2":"Undisclosed","graph3":"The VA Western New York Healthcare System","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Dressing","sponsorNew":"The VA Western New York Healthcare System \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"The VA Western New York Healthcare System \/ Inapplicable"},{"orgOrder":0,"company":"New Horizon Medical Solutions","sponsor":"Amarex Clinical Research","pharmaFlowCategory":"DU","therapeuticArea":"Podiatry","country":"","productType":"Cell and Gene therapy","year":"2025","type":"Inapplicable","leadProduct":"Amnio Matrix","moa":"Undisclosed","graph1":"Podiatry","graph2":"Undisclosed","graph3":"New Horizon Medical Solutions","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"New Horizon Medical Solutions \/ Amarex Clinical Research","highestDevelopmentStatusID":"1","companyTruncated":"New Horizon Medical Solutions \/ Amarex Clinical Research"}]

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check COS database
Check USDMF database

Contact Us
PharmaScopic.com

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Bioiberica

Spain

Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

Lead Product(s) : Tendoactive

Therapeutic Area : Podiatry

Study Phase : Undisclosed

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

The Efficacy of Tendoactive, Eccentric Training, and the Combination of Both as a Treatment of Achilles Tendin...

Details : Undisclosed

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

September 25, 2012

Lead Product(s) : Tendoactive

Therapeutic Area : Podiatry

Highest Development Status : Undisclosed

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Bioiberica Company Banner

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

New Horizon Medical Solutions

Country

ESCRS

Not Confirmed

03

TCI Co., Ltd.

Country

ESCRS

Not Confirmed

04

The First Affiliated Hospital with Nanjing Medical University

Country

ESCRS

Not Confirmed

05

Changi General Hospital

Country

ESCRS

Not Confirmed

06

The VA Western New York Healthcare System

Country

ESCRS

Not Confirmed

07

Oneness Biotech

Taiwan

ESCRS

Not Confirmed

08

Orkla

Sweden

ESCRS

Not Confirmed

09

PolarityTE

U.S.A

ESCRS

Not Confirmed

10

MiMedx

U.S.A

ESCRS

Not Confirmed

1
2